About Dr. Daniel Cameron
A leader in the diagnosis and treatment of Lyme disease and other tick-borne infections.
Leader in Lyme disease research and treatment
He has been at the forefront of Lyme disease research and treatment since the late 1980s and operates a private practice in Mount Kisco, NY, where he treats adolescents and adults suffering from Lyme disease.
Past president of ILADS
Dr. Cameron is the past president of the International Lyme and Associated Diseases Society (ILADS), a nonprofit medical society dedicated to the diagnosis and appropriate treatment of Lyme and other tick-borne diseases.
Author of treatment guidelines for Lyme disease.
He is the lead author of two peer-reviewed treatment guidelines for Lyme disease. The ILADS Treatment Guidelines for the Management of Lyme Disease were first published in 2004, with a second edition released in 2014. These guidelines are widely recognized by physicians trained in treating Lyme disease. Additionally, Dr. Cameron has mentored clinicians through ILADS’ Physician Training Program.
Featured on radio and television programs
As a recognized leader in Lyme disease treatment and diagnosis, Dr. Cameron has been featured on local and national radio and television programs, including CNN, Good Morning America, The Today Show, Fox News, National Public Radio, and DoctorRadio.
Published author and leading researcher
In addition, Dr. Cameron, an internist and epidemiologist, has been involved in clinical research as a principal investigator in the tick-borne illness field and as a sub-investigator for leading pharmaceutical companies. He has published and presented more than 30 scientific papers on various topics related to tick-borne diseases. Many of his papers have been featured in lectures across the United States, Europe, and Canada.
Outspoken advocate for Lyme disease patients
Finally, Dr. Daniel Cameron has been an outspoken advocate for Lyme disease patients. He has provided support and testimony at legislative hearings and public forums nationwide, urging policymakers to adopt laws that advance the standard of care for patients afflicted with tick-borne diseases.